Mounjaro, Zepbound users gained strength with weight training, study finds

Resumen detallado

Adults receiving the drug used in Mounjaro and Zepbound lost less lean tissue when they added three weekly resistance sessions.

Adults taking tirzepatide lost less lean tissue and gained muscle strength when they combined the medication with resistance training, according to a new randomized trial led by researchers at the University of Western Australia.The findings, published November 9 in Nature Medicine, came from a 40-week trial that assigned 120 adults to either three resistance-training sessions a week or their usual activities. Everyone received tirzepatide.Tirzepatide is the active ingredient in Mounjaro and Zepbound. In the US, Mounjaro treats type 2 diabetes, while Zepbound is approved for weight management in eligible adults.

Inicio del artículo, extracto de The Jerusalem Post. Para leer el resto, abra el artículo en el sitio del medio.